![]() |
||||||
| LOW | HIGH |
| Large | |||
| Medium | |||
| Small | |||
| Value | Blend | Growth |
Seeks to provide an above-average level of current income and reasonable long-term capital appreciation.
The Fund invests mainly in common stocks of mid-size and large companies whose stocks typically pay above-average levels of dividend income and are, in the opinion of the purchasing advisor, undervalued relative to other such stocks. In addition, the advisors generally look for companies that they believe are committed to paying dividends consistently. Under normal circumstances, the Fund will invest at least 80% of its assets in equity securities. The Fund uses multiple investment advisors.
| Performance** | 1 Year | 3 Year | 5 Year | 10 Year | ||
|---|---|---|---|---|---|---|
| Fund | Vanguard Equity-Income Fund | 15.09% | 14.00% | 10.34% | 10.84% | |
| Index | FTSE High Dividend Yield Indexi217 | 17.85% | 15.26% | 11.24% | 11.34% | |
| Peer Group | Morningstar Large Value Peer Groupp14 | 15.01% | 14.09% | 9.66% | 10.73% | |
| Expense Ratio (as of 3-31-26)**** | ||||
|---|---|---|---|---|
| Expense Ratio**** | 0.77 | Cost Per $1,000 | $7.70 | |
| Overall Morningstar Rating™: | ★★★★ |
| Overall # of Funds in Category: | 1048 |
| Morningstar Category6A: | Large Value |
| No. of funds: | 3yr 1048; 5yr 983; 10yr 823 |
| The Overall Morningstar Rating™ for the underlying fund is derived from a weighted average of the performance figures associated with its three-, five- and 10-year (if applicable) Morningstar Rating™ metrics. The rating formula most heavily weights the three year rating, using the following calculation: 100% three-year rating for 36-59 months of total returns, 60% five-year rating/40% three-year rating for 60-119 months of total returns, and 50% 10-year rating/30% five-year rating/20% three-year rating for 120 or more months of total returns. Rating does not include the effects of sales charges, loads, and redemption fees. Past performance does not guarantee future results. Ratings are as follows: 3yr=3; 5yr=4; 10yr=4. See Important Notes for the rating criteria. | |
| Top Holdings (as of 12-31-25)¤ | |
|---|---|
| Broadcom Inc | 6.1% |
| Merck & Co Inc | 2.7% |
| JPMorgan Chase & Co | 2.6% |
| Bank of America Corp | 2.6% |
| Johnson & Johnson | 2.4% |
| Cisco Systems Inc | 1.7% |
| ConocoPhillips | 1.6% |
| UnitedHealth Group Inc | 1.6% |
| Gilead Sciences Inc | 1.4% |
| Honeywell International Inc | 1.3% |
| Totals 24.0% of assets | |
| Number of Holdings | 204 |
| Sharpe Ratio | 0.84 |
| Beta | 0.73 (DJ US Total Stock Market TR USD) |
| R² | 64.94 (DJ US Total Stock Market TR USD) |
| Turnover (annualized)§ | 51.00 |
| Net Assets | $65.8 billion |
| Underlying fund expense ratios | • Gross* 0.17% • Net* 0.17% |
| Market Cap (millions) | 98064.78 |
GT-P2459-VEI 05/26